SARS‐CoV‐2 targets neurons of 3D human brain organoids
Open accessPublished version of a preprint
The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
COVID-19 pandemic caused by SARS-CoV-2 infection is a public health emergency. COVID-19 typically exhibits respiratory illness. Unexpectedly, emerging clinical reports indicate that neurological symptoms continue to rise, suggesting detrimental effects of SARS-CoV-2 on the central nervous system (CNS). Here, we show that a Düsseldorf isolate of SARS-CoV-2 enters 3D human brain organoids within 2 days of exposure. We identified that SARS-CoV-2 preferably targets neurons of brain organoids. Imaging neurons of organoids reveal that SARS-CoV-2 exposure is associated with altered distribution of Tau from axons to soma, hyperphosphorylation, and apparent neuronal death. Our studies, therefore, provide initial insights into the potential neurotoxic effect of SARS-CoV-2 and emphasize that brain organoids could model CNS pathologies of COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, organoids can be cultivated over months and probably even years, thus enabling the investigation of tissue maturation in a disease context as shown for SARS-CoV-2 infections in brain organoids87”
From Human disease models in drug development (2023) · cites this paper as [87]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“SARS-CoV-2 tropism for neurons87 and cortical astrocytes88 or its preference for mature cell types and distinct neurotoxic effects were demonstrated in brain organoids.”
From Human disease models in drug development (2023) · cites this paper as [87]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Corman, V. M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D. K., Bleicker, T., Brünink, S., Schneider, J., Schmidt, M. L., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.3.2000045 · Cited by 7,344
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923 · cited 7×
“ACE-2 is an entry receptor for SARS-CoV and efficient replication of SARS-CoV (SARS outbreak in the year 2003) and also depends on the expression level of ACE-2 (Li et al , 2003; Hoffmann et al , 2020).”
InfluentialCerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372 · cited 2×
“We adapted previously described protocol to differentiate iPSCs into brain organoids described earlier (Lancaster et al , 2013; Gabriel et al , 2016).”
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., et al. (2020) · BMJ · doi:10.1136/bmj.m1091 · Cited by 3,903 · cited 1×
“However, emerging case reports showed that patients infected with SARS-CoV-2 suffered a sudden and complete loss of the olfactory function, stroke, and other severe neurological symptoms (Chen et al , 2020; Helms et al , 2020; Poyiadji et al , 2020; Sedaghat & Karimi, 2020; Virani et al , 2020).”
Organogenesis in a dish: Modeling development and disease using organoid technologies
Lancaster, M. A., & Knoblich, J. A. (2014) · Science · doi:10.1126/science.1247125 · Cited by 2,931 · cited 1×
“Cortical neurons are positioned basally to the VZ, forming a cortical plate ) (Lancaster & Knoblich, 2014; Giandomenico & Lancaster, 2017; Gopalakrishnan, 2019).”
Neurologic features in severe SARS-CoV-2 infection
Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., Collange, O., Boulay, C., Fafi-Kremer, S., Ohana, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2008597 · Cited by 2,674
Tau in physiology and pathology
Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251
Baig, A. M., Khaleeq, A., Ali, U., & Syeda, H. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00122 · Cited by 2,207
Research works printed but not linked: 1
- Flint SJ, Racaniello VR, Rall GF, Skalka AM, Enquist LW (2015) Principles of virology. Washington, DC: ASM Press
Cited by
Items 301–400 of 524
Organoids as a novel tool in modelling infectious diseases
de Oliveira, L. F., Filho, D. M., Marques, B. L., Maciel, G. F., Parreira, R. C., Neto, J. R. D. C., da Silva, P. E. F., Guerra, R. O., da Silva, M. V., Santiago, H. C., et al. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.09.003 · Cited by 10
SARS-CoV-2 hampers dopamine production in iPSC-derived dopaminergic neurons
Cappelletti, G., Carsana, E. V., Lunghi, G., Breviario, S., Vanetti, C., Fonzo, A. D., Frattini, E., Magni, M., Zecchini, S., Clerici, M., et al. (2023) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2023.104874 · Cited by 12
Vavougios, G. D., de Erausquin, G. A., & Snyder, H. M. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.1063298 · Cited by 11
Three-Dimensional Cell Culture Methods in Infectious Diseases and Vaccine Research
Varan, G., & Ünal, S. (2023) · Future Pharmacology · doi:10.3390/futurepharmacol3010004 · Cited by 12
Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variantsPreprint
de Melo, G. D., Perraud, V., Alvarez, F., Prado, A. V., Kim, S., Kergoat, L., Coléon, A., Trüeb, B. S., Tichit, M., Piazza, A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.31.505985 · Cited by 10
Recent Advances of COVID-19 Modeling Based on Regenerative Medicine
Larijani, B. A., Heravani, N. F., Abedi, M., Tayanloo-Beik, A., Rezaei–Tavirani, M., Adibi, H., & Arjmand, B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.683619 · Cited by 10
“Hence, more investigation is suggested (Ramani et al., 2020).”
Xu, H. C., Pandey, P., Ward, H., Gorzkiewicz, M., Abromavičiūtė, D., Tinz, C., Müller, L., Meyer, C., Pandyra, A. A., Yavas, A., et al. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300637 · Cited by 8
Self-citationLennol, M. P., García‐Ayllón, M., Avilés-Granados, C., Trasciatti, C., Tolassi, C., Quaresima, V., Arici, D., Cristillo, V., Volonghi, I., Caprioli, F., et al. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf093 · Cited by 9
“Both ACE2 and TMPRSS2 are proteins present in the human and mouse brain cells [9, 10], and it has been demonstrated that human neurons are a target for SARS-CoV-2 [11].”
Targeting mTOR in myeloid cells prevents infection-associated inflammation
Toner, Y. C., Munitz, J., Prévot, G., Morlà‐Folch, J., Wang, W., van Elsas, Y., Priem, B., Deckers, J., Anbergen, T., Beldman, T. J., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112163 · Cited by 9
Mild COVID-19 has no detrimental effect on semen quality
Edimiris, P., Doehmen, C., Müller, L., Andrée, M., Baston-Büst, D. M., Buest, S., Adams, O., Krüssel, J.-S., & Bielfeld, A. P. (2023) · Basic and Clinical Andrology · doi:10.1186/s12610-023-00190-2 · Cited by 13
“The thermal protocol was shortened to 40 cycles of 95 °C [31].”
MethodSelf-citationPost-COVID-19 Cognitive Decline and Apoe Polymorphism: Towards a Possible Link?
Tavares-Júnior, J. W. L., Oliveira, D. N., da Silva, J. B. S., Feitosa, W. L. Q., Sousa, A. V. M., Marinho, S. C., Cunha, L. C. V., Gaspar, S. D. B., Gomes, C. M. P., de Oliveira, L. L. B., et al. (2023) · Brain Sciences · doi:10.3390/brainsci13121611 · Cited by 12
“Ramani et al. evaluated brain organoid neurons and revealed that exposure to SARS-CoV-2 induces stress, whose response leads to aberrant tau protein phosphorylation and apparent neuronal death [24].”
BackgroundComplications in COVID-19 patients. Suggested mechanisms of correction
Khavinson, V. K., & Bi, K. (2020) · Clinical Medicine (Russian Journal) · doi:10.30629/0023-2149-2020-98-4-256-265 · Cited by 13
Viruses as ‘Truffle Hounds’: Molecular Tools for Untangling Brain Cellular Pathology
Müller‐Schiffmann, A., Trossbach, S. V., Lingappa, V. R., & Korth, C. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.11.004 · Cited by 9
“Our group has recently shown that SARS-CoV-2 easily infects brain organoids and targets neurons, where it induces tau mislocalization and hyperphosphorylation [85].”
BackgroundSelf-citationConvergence of human pluripotent stem cell, organoid, and genome editing technologies
Wang, L., Ye, Z., & Jang, Y.-Y. (2021) · Experimental Biology and Medicine · doi:10.1177/1535370220985808 · Cited by 10
In vitro high-content tissue models to address precision medicine challenges
Afewerki, S., Stocco, T. D., Silva, A. D. R., Furtado, A. S. A., de Sousa, G. F., Ruiz‐Esparza, G. U., Webster, T. J., Marciano, F. R., Strømme, M., Zhang, Y. S., et al. (2022) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101108 · Cited by 9
Development trends of human organoid‐based COVID ‐19 research based on bibliometric analysis
Li, M., Yuan, Y., Zou, T., Hou, Z., Jin, L., & Wang, B. (2023) · Cell Proliferation · doi:10.1111/cpr.13496 · Cited by 9
Soto, J., Linsley, C. S., Song, Y., Chen, B., Fang, J., Neyyan, J., Davila, R., Lee, B. S., Wu, B. M., & Li, S. (2023) · Nanomaterials · doi:10.3390/nano13172455 · Cited by 9
Mechanisms of enteric neuropathy in diverse contexts of gastrointestinal dysfunction
Jamka, J. R., & Gulbransen, B. D. (2024) · Neurogastroenterology & Motility · doi:10.1111/nmo.14870 · Cited by 10
Human Brain Organoids: Development and Applications
Hongxi, W., Ruting, W., Yiyang, L., Qinglian, H., Jibing, C., & Feng, J. (2025) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2411.11040 · Cited by 9
“A study assessed the impact of SARS-CoV-2 on the brain using human brain organoids and revealed that the virus primarily infects neurons and has a neurotoxic effect on tau [84].”
Pathophysiology of COVID-19-Associated Neurotoxicity
Cascella, M., & Blasio, E. D. (2021) · Springer eBooks · doi:10.1007/978-3-030-86705-8_1 · Cited by 9
Hsu, P.-C., & Shahed-Al-Mahmud, M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120981 · Cited by 10
“Recent work demonstrated neuron infection of 3D brain organoids model with SARS-CoV-2 and exhibits the SARS-CoV-2 infection enhanced Tau protein level in the somas of neurons [24].”
Luczo, J. M., Edwards, S. J., Ardipradja, K., Suen, W. W., Au, G. G., Marsh, G. A., Gödde, N., Rootes, C. L., Bingham, J., & Sundaramoorthy, V. (2024) · Journal of NeuroVirology · doi:10.1007/s13365-023-01187-3 · Cited by 8
“…models also appears to differ depending on whether culture system is a monolayer of co-cultured neural cells (Bauer et al. 2021, 2022b) or a complex three-dimensional (3D) organoid sys-tem (Zhang et al. 2020; Ramani et al. 2020; Mesci et al. 2022) composed of multiple neural cell types and layers.”
BackgroundResultSadowski, J., Klaudel, T., Rombel‐Bryzek, A., & Bułdak, R. J. (2024) · Biomedical Reports · doi:10.3892/br.2024.1791 · Cited by 9
Evidences of neurological injury caused by COVID‐19 from glioma tissues and glioma organoids
Hu, H., Wang, C., Tao, R., Liu, B., Peng, D., Chen, Y.-K., & Zhang, W. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14822 · Cited by 12
“7,8 Autopsies are often challenged by biosafety and ethical considerations.”
BackgroundCoronavirus 2019: clinical and neuropathological aspects
Younger, D. S. (2020) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000769 · Cited by 9
Modeling SARS-CoV-2 infection in individuals with opioid use disorder with brain organoids
Willner, M. J., Xiao, Y., Kim, H. S., Chen, X., Xu, B., & Leong, K. W. (2021) · Journal of Tissue Engineering · doi:10.1177/2041731420985299 · Cited by 10
Human Organoids as a Promising Platform for Fighting COVID-19
Chen, D., Su, X., Chen, H., Chen, S., Zhao, Y., & Wei, W. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.64993 · Cited by 9
“, revealed that SARS-CoV-2 could infect human brain organoids within two days of virus exposure [52].”
BackgroundHarbuzariu, A., Nti, A., Harp, K. O., Cespedes, J. C., Driss, A., & Stiles, J. K. (2022) · iScience · doi:10.1016/j.isci.2022.104407 · Cited by 9
“Another study reported that SARS-CoV-2, the virus responsible for COVID-19, preferably targets neurons using brain organoids (Ramani et al., 2020), which was confirmed by the detection of the virus in cortical neurons from postmortem brain samples (Song et al., 2021).”
BackgroundNoorani, B., Cucullo, L., Ahn, Y., Kadry, H., Bhalerao, A., Raut, S., Nozohouri, E., & Chowdhury, E. A. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220706112711 · Cited by 9
“, in another fascinating study, demonstrated that within two days of exposure to SARS-CoV-2, the virus enters the 3D human brain organoid models and consequently targets the neurons [133].”
ResultOrganoid Technology and the COVID Pandemic
Sanyal, R., & Paul, M. K. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98542 · Cited by 9
Human Brain In Vitro Model for Pathogen Infection-Related Neurodegeneration Study
Yan, Y., & Cho, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126522 · Cited by 7
“Ramani et al. revealed that SARS-CoV-2 prefers mature neuronal cell types, as indicated by higher infection rates in Day-60 brain organoids compared to Day-15 organoids [176].”
BackgroundPacnejer, A.-M., Butucă, A., Dobrea, C. M., Arseniu, A. M., Frum, A., Gligor, F. G., Arseniu, R., Vonica, R. C., Vonica-Țincu, A. L., Oancea, C. I., et al. (2024) · Viruses · doi:10.3390/v16121811 · Cited by 8
“Most studies in the literature also indicate that brain infiltration by the SARS-CoV-2 virus or its viral proteins might, potentially, cause neurological deficits in infected individuals, although it is known that coronaviruses are not primarily neurotropic viruses [25,62,72–74].”
The Role of TDP-43 in SARS-CoV-2-Related Neurodegenerative Changes
Kim, D., Kim, J., Jeon, M., Kim, K., Kim, D.-G., & Choi, I.-S. (2025) · Viruses · doi:10.3390/v17050724 · Cited by 10
“Additionally, SARS-CoV-2 infection induces redistribution of heparin-binding proteins from the axons to the soma and their subsequent hyperphosphorylation [87].”
Organoids as platforms for infectious disease research
Liu, K., Zhao, Y., Joloya, E. M., Artegiani, B., Bartfeld, S., Choi, Y. K., Han, Y., Hendriks, D. F. G., Hoogduijn, M. J., Hudson, J. E., et al. (2026) · Nature Reviews Bioengineering · doi:10.1038/s44222-026-00445-3 · Cited by 8
“In addition, brain organoids have provided insights into SARS-CoV-2 infection, revealing the predominant mechanism of damage to the choroid plexus epithelium 98 and neuronal cell death 99,100 .”
Postcovid syndrome — a new reality
Хорева, М. А. (2021) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2021121101131 · Cited by 10
Suárez-Meade, P., Watanabe, F., Ruiz-Garcia, H. J., Rafferty, S. B., Garcia, D. P. M., Schiapparelli, P. V., Jentoft, M. E., Imitola, J., & Quiñones‐Hinojosa, A. (2023) · Journal of Neuro-Oncology · doi:10.1007/s11060-022-04205-2 · Cited by 10
Cappelletti, G., Colombrita, C., Limanaqi, F., Invernizzi, S., Garziano, M., Vanetti, C., Moscheni, C., Santangelo, S., Zecchini, S., Trabattoni, D., et al. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1285836 · Cited by 7
The European Academy of Neurology N euro COVID ‐19 Task Force: A lesson for the future
Cavallieri, F., Sellner, J., Akhvlediani, T., Bassetti, C. L., Bereczki, D., Fanciulli, A., Filipović, S. R., Guekht, A. B., Helbok, R., Hochmeister, S., et al. (2024) · European Journal of Neurology · doi:10.1111/ene.16321 · Cited by 6
SARS-CoV-2 Nucleocapsid Protein Induces Tau Pathological Changes That Can Be Counteracted by SUMO2
Orsini, F., Bosica, M., Martucci, A., Paola, M. D., Comolli, D., Pascente, R., Forloni, G., Fraser, P. E., Arancio, O., & Fioriti, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137169 · Cited by 8
“A study in brain organoids revealed that SARS-CoV-2 alters the phosphorylation and distribution of Tau in infected neurons [10], but the mechanisms are currently unknown.”
BackgroundResultNeurotropism and blood-brain barrier involvement in COVID-19
Fujimoto, T., Erickson, M. A., & Banks, W. A. (2022) · Frontiers in Drug Delivery · doi:10.3389/fddev.2022.1073815 · Cited by 7
“Experiments on 3D human brain organoids similarly show that SARS-CoV-2 can enter the cells and have the potential neurotoxic effect (Ramani et al., 2020; Song et al., 2021).”
BackgroundWhat Can We Still Learn from Brain Autopsies in COVID-19?
Solomon, I. H., Singh, A., Folkerth, R. D., & Mukerji, S. S. (2023) · Seminars in Neurology · doi:10.1055/s-0043-1767716 · Cited by 7
Chandrasegaran, P. R. G., Lestari, A. N., Sinton, M. C., Gopalakrishnan, J., & Quintana, J. F. (2023) · F1000Research · doi:10.12688/f1000research.131507.1 · Cited by 6
Self-citationMignolet, M., Gilloteaux, J., Halloin, N., Gueibe, M., Willemart, K., Swert, K. D., Bielarz, V., Suain, V., Pastushenko, I., Gillet, N. A., et al. (2023) · Viruses · doi:10.3390/v15102020 · Cited by 7
Antiandrogens as Therapies for COVID-19: A Systematic Review
Cani, M., Epistolio, S., Dazio, G., Modesti, M., Salfi, G., Pedrani, M., Isella, L., Gillessen, S., Vogl, U. M., Tortola, L., et al. (2024) · Cancers · doi:10.3390/cancers16020298 · Cited by 10
COVID‐19 lessons from the dish: Dissecting CNS manifestations through brain organoids
Caporale, N., & Testa, G. (2020) · The EMBO Journal · doi:10.15252/embj.2020107213 · Cited by 6
Wang, C., Dinesh, R. K., Qu, Y., Rustagi, A., Cousins, H. C., Zengel, J. R., Zhang, T., Magazine, N., Guo, Y., Hall, T. O., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.01.450475 · Cited by 9
Lamoureux, L., Sajesh, B. V., Slota, J. A., Medina, S. J., Mayor, M., Frost, K. L., Warner, B. M., Manguiat, K., Wood, H., Kobasa, D., et al. (2022) · Viruses · doi:10.3390/v14061218 · Cited by 6
Understanding the neurological implications of acute and long COVID using brain organoids
García‐González, L., Martí-Sarrias, A., Puertas, M. C., Bayón-Gil, Á., Resa‐Infante, P., Martínez‐Picado, J., Navarro, A., & Acosta, S. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.050049 · Cited by 8
“Acute COVID Long COVID (cid:129) SARS-CoV-2 detection (Paniz-Mondolfi et al., 2020; McMahon et al., 2021; Andrews et al., 2022; Ramani et al., 2020; Yi et al., 2020; Zhang et al., 2020) (cid:129) Astrogliosis (Duarte-Neto et al., 2020; Kanberg et al., 2020; Matschke et al., 2020; Andrews et al.,…”
InfluentialDeveloping brain under renewed attack: viral infection during pregnancy
Recaioglu, H., & Kolk, S. M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1119943 · Cited by 6
“Nonetheless, dose-dependent CNS infectivity of SARS-COV-2 was not consistently reported (Ramani et al., 2020; Yi et al., 2020; Kumari et al., 2021), maybe suggesting a more prominent role of entry mediator expression level compared to viral load.”
BackgroundMartín-López, E., Brennan, B., Mao, T., Spence, N. J., Meller, S. J., Han, K., Yahiaoui, N., Wang, C., Iwasaki, A., & Greer, C. A. (2024) · eNeuro · doi:10.1523/eneuro.0106-24.2024 · Cited by 6
“Several reports present compelling evidence of neuronal infection (Paniz-Mondol fi et al., 2020; Ramani et al., 2020; Burks et al., 2021; de Melo et al., 2021; Meinhardt et al., 2021; Song et al., 2021; Cappelletti et al., 2023; Yang et al., 2024), while others reported no direct infection of…”
BackgroundThimet Oligopeptidase—A Classical Enzyme with New Function and New Form
Liu, Y., Sigman, J. A., Bruce, L. A., & Wolfson, A. J. (2021) · Immuno · doi:10.3390/immuno1040022 · Cited by 6
COVID-19 – prime time for microphysiological systems, as illustrated for the brain
Kang, I., Smirnova, L., Kuhn, J. H., Hogberg, H. T., Kleinstreuer, N. C., & Hartung, T. (2021) · ALTEX · doi:10.14573/altex.2110131 · Cited by 6
Kodidela, S., Godse, S., Kumar, A., Nguyen, X. H., Cernasev, A., Zhou, L., Singh, A. K., Bhat, H. K., & Kumar, S. (2022) · Biology · doi:10.3390/biology11020177 · Cited by 6
“As observed in the case of HIV infection, there is a high probability that SARS-CoV-2 can enter the brain and cause neurological complications [6,7].”
BackgroundUsing 2D and 3D pluripotent stem cell models to study neurotropic viruses
LaNoce, E., Dumeng-Rodriguez, J., & Christian, K. M. (2022) · Frontiers in Virology · doi:10.3389/fviro.2022.869657 · Cited by 7
Neurotropic SARS-CoV-2: Causalities and Realities
Pardasani, M., & Abraham, N. M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.108573 · Cited by 7
Organoids to Remodel SARS-CoV-2 Research: Updates, Limitations and Perspectives
An, Y., He, Y., Ge, N., Guo, J., Yang, F., & Sun, S. (2023) · Aging and Disease · doi:10.14336/ad.2023.0209 · Cited by 7
“to generate downstream effects that induced stress and cell death [99].”
BackgroundYounger, D. S. (2021) · World Journal of Neuroscience · doi:10.4236/wjns.2021.111003 · Cited by 6
“These mechanisms were captured in a recent study by Ramani and coworkers [11] employing a brain organoid model.”
The Neurobiology of Modern Viral Scourges: ZIKV and COVID-19
Mittal, S., Federman, H. G., Sievert, D., & Gleeson, J. G. (2021) · The Neuroscientist · doi:10.1177/10738584211009149 · Cited by 8
Groppa, S. A., Ciolac, D., Duarte, C. L., Garcia, C., Gasnaș, D., Leahu, P., Efremova, D., Alexandru, G., Bălănuță, T., Mîrzac, D., et al. (2021) · Advances in experimental medicine and biology · doi:10.1007/5584_2021_675 · Cited by 7
Onaolapo, A. Y., & Onaolapo, O. J. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666211222162811 · Cited by 6
Vavougios, G. D. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104733 · Cited by 9
“Currently, three lines of evidence on SARS-CoV-2’s neurotropism: (a) an infection experiment on brain organoids indicating the priming of tau pathology,(Ramani et al., 2020) (b) the emergence of COVID-19 associated parkinsonism(Merello et al.”
BackgroundRepositioned Drugs for COVID-19—the Impact on Multiple Organs
Chan, C., Foster, S. T., Chan, K. G., Cacace, M. J., Ladd, S., Sandum, C. T., Wright, P. T., Volmert, B. D., Yang, W., Aguirre, A., et al. (2021) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-021-00874-8 · Cited by 5
Crawford, G., Soper, O., Kang, E., & Berg, D. A. (2024) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2024.35 · Cited by 5
“Organoid studies have demonstrated SARS-CoV-2 ’ s capability to infect mature neurons, demonstrated by the co-localisation of MAP2 + and TUJ-1 + cells with viral components such as the nucleocapsid protein (NP), Spike protein and viral RNA (Refs 50, 59, 60).”
InfluentialAdvances in eye-brain axis: Anatomy, immunity, and association with visual dysfunction
Zhang, S., Fan, Z., & Ji, D. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102925 · Cited by 7
Vashisht, A., Vashisht, V., Singh, H., Ahluwalia, P. K., Mondal, A. K., Williams, C., Farmaha, J. K., Woodall, J., & Kolhe, R. B. (2024) · Viruses · doi:10.3390/v16081183 · Cited by 6
Cappelletti, G., Brambilla, L., Strizzi, S., Limanaqi, F., Melzi, V., Rizzuti, M., Nizzardo, M., Saulle, I., Trabattoni, D., Corti, S. P., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202401604rrr · Cited by 5
Neuro–Immune Interactions in Severe COVID-19 Infection
Rossi, E. G., Mutti, L., Morrione, A., & Giordano, A. (2022) · Pathogens · doi:10.3390/pathogens11111256 · Cited by 8
“An intriguing study of human brain organoids revealed that even a low level of ACE2 is sufficient for viral entry into neurons [88].”
BackgroundHost-Cell Surface Binding Targets in SARS-CoV-2 for Drug Design
Tabatabai, S. A., Maleksabet, H., & Rezaee, E. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612829666221123111849 · Cited by 6
Emerging Landscape of Preclinical Models for Studying COVID-19 Neurologic Diseases
Li, J., Wang, J., & Wang, H. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00127 · Cited by 5
Extracellular Vesicles: The Invisible Heroes and Villains of COVID‐19 Central Neuropathology
Chang, H., Chen, E., Hu, Y., Wu, L., Deng, L., Ye, S., Mao, X., Zhu, T., Liu, J., & Chen, C. (2023) · Advanced Science · doi:10.1002/advs.202305554 · Cited by 4
Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19
Lengacher, N. A., Tomlinson, J. J., Jochum, A.-K., Franz, J., Ali, O. H., Flatz, L., Jochum, W., Penninger, J. M., aSCENT-PD Investigators, Arenkiel, B. R., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01761-8 · Cited by 6
“The existence of tau and αSyn co-pathology in almost all of the synucleinopathy cases in our series suggests that the molecular mechanisms, which underlie the frequent co-existence of these changes in the brains of AD and LBD patients, are also operative in the intracranial olfactory circuitry.”
BackgroundVavougios, G. D., Mavridis, T., Doskas, T. K., Papaggeli, O., Foka, P., & Hadjigeorgiou, G. M. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050277 · Cited by 6
Choi, J. Y., Mahadik, B. P., & Fisher, J. P. (2021) · Essays in Biochemistry · doi:10.1042/ebc20200105 · Cited by 5
Opportunities and Challenges of Human IPSC Technology in Kidney Disease Research
Lee, J., Lin, C., Chen, H., Hsieh, P. C. H., Chiu, Y., & Chang, J. (2022) · Biomedicines · doi:10.3390/biomedicines10123232 · Cited by 6
“The iPSC-derived cardiomyocyte (iPSC-CM) experiments showed that SARS-CoV-2 can enter iPSC-CM via ACE2, replicate, and cause cytopathic effects including apoptosis and cessation of beating.”
ResultInfluentialIntracranial Aneurysm Rupture after SARS-CoV2 Infection: Case Report and Review of Literature
Khan, D., Naderi, S., Ahmadi, M., Ghorbani, A., Cornelius, J. F., Hänggi, D., & Muhammad, S. (2022) · Pathogens · doi:10.3390/pathogens11060617 · Cited by 8
“Moreover, COVID-19 has been shown to infect neurons of human brain organoids [21,22], and COVID-19 was detected in the cortical neurons in brain autopsies of COVID-19 patients [22].”
SARS-CoV-2 causes human BBB injury and neuroinflammation indirectly in a linked organ chip platformPreprint
Wang, P., Jin, L., Zhang, M., Wu, Y., Duan, Z., Chen, W., Wang, C., Liao, Z., Han, J.-B., Guo, Y., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.05.463205 · Cited by 5
Charnley, M., Islam, S., Bindra, G. K., Engwirda, J., Ratcliffe, J., Zhou, J., Mezzenga, R., Hulett, M. D., Han, K., Berryman, J. T., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1201481/v1 · Cited by 5
Kanupriya, K., Verma, S., Sharma, V., Mishra, I., & Mishra, R. (2025) · Current Drug Research Reviews · doi:10.2174/0125899775369286250206050006 · Cited by 5
Adult and childhood vasculitis
Younger, D. S. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98818-6.00008-x · Cited by 5
Sheng, H., Liang, Y., Lauschke, V. M., & Wang, Y. (2025) · Engineering · doi:10.1016/j.eng.2025.01.019 · Cited by 6
Neurocognitive Impairment After COVID-19: Mechanisms, Phenotypes, and Links to Alzheimer’s Disease
Doskas, T. K., Vavougios, G. D., Kormas, C., Kokkotis, C., Tsiptsios, D., Spiliopoulos, K. C., Tsiakiri, A., Christidi, F., Aravidou, T., Dekavallas, L., et al. (2025) · Brain Sciences · doi:10.3390/brainsci15060564 · Cited by 11
Does COVID-19 Affect Adult Neurogenesis? A Neurochemical Perspective
Saikarthik, J., Saraswathi, I., & Al-Atram, A. A. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.101179 · Cited by 4
“The consequence of this is not known however, viral entry may trigger apoptotic pathways and cause excitatory-inhibitory imbalance, and lead to neuronal death [149].”
BackgroundSingh, S. K., Kumar, A., & Sharma, H. (2022) · Recent Patents on Biotechnology · doi:10.2174/1872208316666220124101611 · Cited by 4
Postcovid Syndrome – The New Reality
Хорева, М. А. (2022) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-022-01286-4 · Cited by 5
Hydrogen sulfide: From a toxic gas to a potential therapy for COVID-19 and inflammatory disorders
Kumar, M. (2023) · Nitric Oxide · doi:10.1016/j.niox.2023.08.002 · Cited by 4
Tau protein aggregation associated with SARS-CoV-2 main proteasePreprint
Eberle, R. J., Coronado, M. A., Gering, I., Korostov, K., Stefanski, A., Stühler, K., Kraemer‐Schulien, V., Blömeke, L., Bannach, O., & Willbold, D. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.04.531078 · Cited by 4
Acharya, A., Ambikan, A. T., Thurman, M., Malik, M. R., Dyavar, S. R., Végvári, Á., Neogi, U., & Byrareddy, S. N. (2023) · Research Square · doi:10.21203/rs.3.rs-3031591/v1 · Cited by 5
Membrane-wide screening identifies potential tissue-specific determinants of SARS-CoV-2 tropism
Dinesh, R. K., Wang, C., Qu, Y., Rustagi, A., Cousins, H. C., Zengel, J. R., Wang, X., Barnard, T. R., Johnson, W. A., Xu, G., et al. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013157 · Cited by 5
Segabinazi, E., Tocantins, F. R., Glaser, T., Maglio, T. G., Oliveira, N. C., Castanha, A. G., Russo, F. B., Leite, P. E. C., Brito, A., Molina, C. V., et al. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101115 · Cited by 4
“…studies (Rockx et al., 2020; Chan et al., 2020), postmortem brain analyses (Younger, 2021; Menezes et al., 2022), three-dimensional in vitro models (Ramani et al., 2020; Zhang et al., 2020), and two-dimensional co-cultures of human neural cells have proven instrumental in elucidating the complex…”
Pluripotent stem cells-based neural organoids for modelling human brain development and diseases
Tong, L., Tian, P., Wang, R., Niu, S., Wang, R., Ye, Y., Wu, Y., Zhang, W., Wang, Y., Foggetti, A., et al. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01515-6 · Cited by 3
“These findings provide critical experimental evidence that helps explain the neuropsychological complications associated with COVID-19 [261, 262].”
Organoids in COVID-19: can we break the glass ceiling?
Chau, C. W., & Sugimura, R. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad098 · Cited by 3
Basak, I., Harfoot, R., Palmer, J. E., Kumar, A., Quiñones‐Mateu, M. E., Schweitzer, L., & Hughes, S. M. (2023) · Biomolecules · doi:10.3390/biom13111597 · Cited by 4
“A similar observation was made by Ramani et al. [65] when they exposed human brain organoids to SARS-CoV-2.”
BackgroundMethodResultInfluentialPassos, V., Henkel, L. M., Wang, J., Belinchón, F. J. Z., Moeller, R. A., Sun, G., Waltl, I., Schneider, T., Wachs, A. S., Ritter, B., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29455 · Cited by 3
Chen, W., Jiang, X., Liang, W. P., Bai, H., Xu, M., Liu, Z., Yi, L., Liu, Y., Huang, Y., Zhang, Y., et al. (2024) · Research · doi:10.34133/research.0376 · Cited by 5
“There are several studies that have reported that SARS-CoV-2 is able to infect human induced-pluripotent-stem-cell-derived brain organoids/neurons but that this infection is abortive and does not result in virus spread to other cells [16,23].”
BackgroundMethodResultLong COVID psychiatric sequelae, biochemical markers & tau protein: A 3-year follow-up study
Jaiswal, S., Sahoo, S., Dhiman, V., Sachdeva, N. K., Singh, M. P., Ram, S., Sharma, G., & Bhadada, S. K. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116413 · Cited by 4
Ex vivo study of neuroinvasive and neurotropic viruses: what is current and what is next
Lalande, A., & Mathieu, C. (2025) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaf024 · Cited by 4
Katoh, M., & Katoh, M. (2021) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2021.720577 · Cited by 3
“Preclinical studies using patient-derived cell lines, organoids and xenograft as well as animal models, such as monkey, mouse, Xenopus and zebrafish, are driving apparatuses for mechanistic understanding, target discovery and therapeutic optimization (Ramani et al., 2020; Rockx et al., 2020).”
MethodBrain organoids for addressing COVID-19 challenge
Yu, J. S., Wang, K., & Zheng, D. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1055601 · Cited by 3
“But others have pointed out that low levels of IFN I and III with elevated chemokines and high expression of IL-6 are key to the development of neuroinflammatory symptoms, even more importantly, infected astrocytes are involved in neuroinflammation through upregulation of inflammation-related genes such as IFIT1, IFI4…”
BackgroundTavares-Júnior, J. W. L., Ciurleo, G. C. V., Feitosa, E. D. A. A. F., Oriá, R. B., & Braga‐Neto, P. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231368 · Cited by 3
Interactions of SARS-CoV-2 with Human Target Cells—A Metabolic View
Eisenreich, W., Leberfing, J., Rudel, T., Heesemann, J., & Goebel, W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189977 · Cited by 5
“However, pluripotent stem cell-derived neurons also express ACE2 [230], and studies with 3D human brain organoids derived from pluripotent stem cells provided evidence that SARS-CoV-2 infects neurons but not astrocytes [239,240].”
Background
Metadata
- Authors
- Ramani, A., Müller, L., Ostermann, P. N., Gabriel, E., Abida‐Islam, P., Müller‐Schiffmann, A., Mariappan, A., Goureau, O., Gruell, H., Walker, A., Andrée, M., Hauka, S., Houwaart, T., Dilthey, A., Wohlgemuth, K., Omran, H., Klein, F., Wieczorek, D., Adams, O., Timm, J., Korth, C., Schaal, H., & Gopalakrishnan, J.
- Affiliations
- Düsseldorf University Hospital (DE)
- Centre National de la Recherche Scientifique (FR)
- University of Cologne (DE)
- University Hospital Münster (DE)
- Corresponding author
- Schaal, Heiner
- Gopalakrishnan, Jay
- ORCID
- Ramani, Anand
- Müller, Lisa
- Ostermann, Philipp N
- Gabriel, Elke
- Müller‐Schiffmann, Andreas
- Mariappan, Aruljothi
- Goureau, Olivier
- Gruell, Henning
- Walker, Andreas
- Houwaart, Torsten
- Dilthey, Alexander
- Wohlgemuth, Kai
- Omran, Heymut
- Wieczorek, Dagmar
- Adams, Ortwin
- Timm, Jörg
- Korth, Carsten
- Schaal, Heiner
- Gopalakrishnan, Jay
- Venue
- The EMBO Journal
- Published
- 2020-09-23
- Volume
- 39
- Issue
- 20
- Pages
- e106230-e106230
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC7560208
- OpenAlex
- W3081536095
- Cited by
- 518
- References
- 63
- Citations by year
- 2026: 16 · 2025: 39 · 2024: 71 · 2023: 85 · 2022: 126 · 2021: 145 · 2020: 36
- FWCI
- 42.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- creativecommons.org/licenses/by-nc-nd/4.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Locations
- The EMBO Journal (publishedVersion, other-oa)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- HAL (submittedVersion, other-oa)
- Funders
- Fritz Thyssen Stiftung (10.17.2.018MN)
- Juergen Manchot Foundation
- Topics
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, COVID-19 pandemic, brain organoids, neuronal infection, neurotoxicity, tau hyperphosphorylation, neuronal cell death, central nervous system pathology
- MeSH terms
- Betacoronavirus, SARS-CoV-2, Animals, Brain, Chlorocebus aethiops, Humans, Nervous System Diseases, Neurons, Organoids, Vero Cells, tau Proteins, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.